A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial Fibrillation

NCT00787150 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

222

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Apixaban
DRUG: Apixaban
DRUG: Warfarin sodium

Sponsor

Pfizer

Collaborators

[object Object]